Global Viral Infections Market to 2021
Report Description Viruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021.
Continued…
Scope
The viral infections market is large and growing rapidly
The pipeline is innovative and diverse
Considerable market growth is anticipated throughout 2021
Deal values for licensing and co-development deals range considerably
Download FREE REPORT sample @ https://www.24marketreports.com/request-sample/glo bal-viral-infections-market-to-2021--promising-new-competitors-and-expanding-treatmentpopulation-to-offset-increased-uptake-of-generics
Table of Contents 1 Table of Contents 4 2 Introduction 9 3 Marketed Products 22 4 Pipeline 42 5 Multi-scenario Market Forecast to 2021 71 6 Company Analysis and Positioning 87 7 Strategic Consolidations 90
Visit us at : https://www.24marketreports.com/life-sciences/globalviral-infections-market-to-2021--promising-new-competitors-and-expanding-treatment-po pulation-to-offset-increased-uptake-of-generics Stay With Us :
Int'l: (+1) 646 781 7170 Email: help@24marketreports.com
New York City Zone 01, NY, United States.